Financhill
Sell
31

ZVRA Quote, Financials, Valuation and Earnings

Last price:
$7.84
Seasonality move :
-6.77%
Day range:
$7.77 - $7.99
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.37x
P/B ratio:
10.71x
Volume:
211.5K
Avg. volume:
454.2K
1-year change:
35.34%
Market cap:
$424.8M
Revenue:
$23.6M
EPS (TTM):
-$2.26

Earnings Data

Next earnings date for ZVRA
May 08
2025
Most recent earnings per share
-$0.69
Missed by $0.29
(Mar 11/2025)
Consensus Estimate
-$0.40
(Mar 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZVRA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $17M -- -- -$0.19 --
03/11/2025 Q4 $8.9M $12M -$0.69 -$0.40 -$0.29
11/12/2024 Q3 $4.9M $3.7M -$0.69 -$0.41 -$0.28
08/13/2024 Q2 $4.4M $4.4M -$0.48 -$0.44 -$0.04
05/08/2024 Q1 $3.8M $3.4M -$0.40 -$0.48 $0.08
03/28/2024 Q4 $11.7M $12.9M -$0.54 -$0.27 -$0.27
11/07/2023 Q3 $3.4M $2.9M -$0.30 -$0.30 -$0.00
08/14/2023 Q2 $3M $8.5M -$0.08 -$0.34 $0.26
05/15/2023 Q1 $2.7M $3.2M -$0.38 -$0.23 -$0.15
03/07/2023 Q4 $3.1M $2M $0.16 -$0.18 $0.34
11/09/2022 Q3 -- $2.9M -$0.19 -- --
06/30/2022 Q2 -- $1.3M -$0.70 -- --
03/31/2022 Q1 -- $4M -$0.05 -- --
12/31/2021 Q4 -- $2.6M $0.05 -- --
09/30/2021 Q3 -- $2M -$0.05 -- --
06/30/2021 Q2 -- $12M -$0.40 -- --
03/31/2021 Q1 -- $12.1M -$2.49 -- --
12/31/2020 Q4 -- $2.4M -$1.13 -- --
09/30/2020 Q3 -- $1.9M -$0.68 -- --
06/30/2020 Q2 -- $6.9M $0.21 -- --
03/31/2020 Q1 -- $2.1M -$1.92 -- --
12/31/2019 Q4 -- $1.4M -$2.83 -- --
09/30/2019 Q3 -- $11.5M $0.96 -- --
06/30/2019 Q2 -- -- -$5.28 -- --
03/31/2019 Q1 -- -- -$7.36 -- --
12/31/2018 Q4 -- -- $2.88 -- --
09/30/2018 Q3 -- -- -$15.04 -- --
06/30/2018 Q2 -- -- -$14.56 -- --
03/31/2018 Q1 -- -- -$28.32 -- --
12/31/2017 Q4 -- -- -$11.52 -- --
09/30/2017 Q3 -- -- -$10.88 -- --
06/30/2017 Q2 -- -- -$7.04 -- --
03/31/2017 Q1 -- -- -$17.76 -- --
12/31/2016 Q4 -- -- -$10.88 -- --
09/30/2016 Q3 -- -- -$14.72 -- --
06/30/2016 Q2 -- -- $9.28 -- --
03/31/2016 Q1 -- -- -$3.20 -- --
12/31/2015 Q4 -- -- -$10.24 -- --
09/30/2015 Q3 -- -- -$10.88 -- --
06/30/2015 Q2 -- -- -$39.20 -- --
03/31/2015 Q1 -- -- -$7.77 -- --

Zevra Therapeutics Earnings Questions

  • How Much did Zevra Therapeutics Generate in Revenue Last Quarter?

    Zevra Therapeutics reported $12M worth of top line sales in its most recent quarter.

  • Did Zevra Therapeutics Beat Earnings Last Quarter?

    Zevra Therapeutics announced earnings per share of -$0.69 which represents a miss of analyst forecast a -$0.40 per share.

  • Is Zevra Therapeutics Profitable?

    Zevra Therapeutics reported $10.7M that represents $0.20 per share over the last quarter.

  • What is the Analyst Consensus for Zevra Therapeutics EPS Next Year?

    Zevra Therapeutics's earnings are forecast to decrease from -$2.28 per share to $0.11 per share next year representing a decrease of -76.84%.

  • When is Zevra Therapeutics's Earnings Date?

    Zevra Therapeutics's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Why Did Buffett Sell the S&P 500?
Why Did Buffett Sell the S&P 500?

Warren Buffett has always been an advocate of investing in…

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

Sell
24
AIR alert for Mar 29

AAR [AIR] is down 16.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock